Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2014
10/23/2014US20140314758 Immunogenic tumor associated stromal cell antigen peptides and methods of their use
10/23/2014US20140314757 Phytocannabinoids for use in the treatment of breast cancer
10/23/2014US20140314756 Method for treating psoriasis
10/23/2014US20140314753 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314752 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314751 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314749 Compositions and methods for diagnosis and treatment of hepatic cancers
10/23/2014US20140314748 Antibody formulations
10/23/2014US20140314746 Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
10/23/2014US20140314742 Endoglin antibodies
10/23/2014US20140314739 Vaccine adjuvant composition comprising inulin particles
10/23/2014US20140314714 Immunopotentiative composition
10/23/2014US20140314710 IL-12 P40 Monomer, Monoclonal Antibody Against P40 Homodimer and the Combination of the Two for Autoimmune Disease Treatment
10/23/2014US20140314708 Dual delivery system for heterologous antigens
10/23/2014US20140314707 Immunostimulating Polyphosphazene Compounds
10/23/2014US20140314703 Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof
10/23/2014US20140314675 Cancer stem cell isolation
10/23/2014US20140314653 Method for preparation of aluminum hydroxyphosphate adjuvant
10/21/2014US8865870 Anti-CXCR3 antibodies and methods of use thereof
10/21/2014US8865866 Diphtheria toxin variant
10/21/2014US8865679 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
10/21/2014US8865657 Compositions and methods for inactivating or suppressing inflammatory cells
10/21/2014US8865653 Method of treatment for immunogenic treatment resistant cancer
10/21/2014US8865648 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
10/21/2014US8865469 Methods of transforming a Listeria
10/21/2014US8865461 Rabies virus vector systems and compositions and methods thereof
10/21/2014US8865431 Antigen binding domains
10/21/2014US8865430 Fusion polypeptides capable of activating receptors
10/21/2014US8865422 Method for the diagnosis of tuberculosis
10/21/2014US8865419 Method for the screening of conserved secreted proteins
10/21/2014US8865398 Combination hepatitis C virus antigen and antibody detection method
10/21/2014US8865186 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
10/21/2014US8865185 Methods of use for HSV-1 and HSV-2 vaccines
10/21/2014US8865184 Vaccine for chikungunya virus infection
10/21/2014US8865183 Treatment of pigs with PCV2 antigent
10/21/2014US8865182 Adenoviral-based vectors
10/21/2014US8865180 Compounds and methods for diagnosis and treatment of leishmaniasis
10/21/2014US8865179 Aptameric IgE peptides in a protein scaffold as an allergy vaccine
10/21/2014US8865178 Compositions and methods for wound healing
10/21/2014US8865177 Pressure sore treatment
10/21/2014US8865176 Methods and compositions for generating bioactive assemblies of increased complexity and uses
10/21/2014US8865175 Increasing anti-IL-1α antibodies in a subject
10/21/2014US8865174 Methods of treatment using human antibodies that bind IL-12
10/21/2014US8865173 Treatments for pancreatic cancer metastases
10/21/2014US8865171 Soluble forms of Hendra and Nipah virus G glycoprotein
10/21/2014US8865170 Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
10/21/2014US8865169 Methods and systems for multi-antibody therapies
10/21/2014US8865168 Methods and compositions to regulate hepcidin expression
10/21/2014US8865167 Neutralising antibody molecules having specificity for human IL-17
10/21/2014US8865166 Antibodies to IL-17A and uses thereof
10/21/2014US8865165 Monoclonal antibody against group 2 allergen of Dermatophagoides pteronyssiuns, hybridoma cell line producing thereof, strip, kit and method using said monoclonal antibody for dust mite assay
10/21/2014US8865164 Detecting complement activation
10/21/2014US8865163 Pharmaceutical compositions and methods of treatment
10/21/2014US8865162 Monoclonal antibodies against HPV proteins
10/21/2014US8865127 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
10/16/2014US20140308341 Methods and compositions for liposomal formulation of antigens and uses thereof
10/16/2014US20140308318 Inhibitors against Endosomal/Lysosomal Enzymes
10/16/2014US20140308316 Antigen presenting cancer vaccine with gamma interferon
10/16/2014US20140308315 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
10/16/2014US20140308313 Compositions and methods for immunisation using cd1d ligands
10/16/2014US20140308312 Use of micrornas to control virus helper nucleic acids
10/16/2014US20140308311 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
10/16/2014US20140308308 Compositions and methods for treatment of cytomegalovirus
10/16/2014US20140308305 Yeast-Based Vaccines as Immunotherapy
10/16/2014US20140308300 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/16/2014US20140308299 Combination Immunotherapy for the Treatment of Cancer
10/16/2014US20140308296 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
10/16/2014US20140308292 Family of pain producing substances and methods to produce novel analgesic drugs
10/16/2014US20140308291 Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308284 Method of combination therapy using anti-c-met antibody and fgfr inhibitor
10/16/2014US20140308283 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
10/16/2014US20140308281 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
10/16/2014US20140308279 Anti-ErbB3 Antibodies and Uses Thereof
10/16/2014US20140308275 Methods for diagnosing and treating myhre syndrome
10/16/2014US20140308271 Antibodies that bind to tl1a and their uses
10/16/2014US20140308269 Humanized antibodies
10/16/2014US20140308238 Immunomodulating compositions and methods of use thereof
10/14/2014USRE45196 Compositions comprising structurally stable conjugate molecules
10/14/2014US8859740 Anti-infective binding proteins that bind AIP2
10/14/2014US8859739 Anti-huTNFR1 antibody and methods of use thereof for treatment
10/14/2014US8859737 Anti-HER3 antibodies and uses thereof
10/14/2014US8859509 Chimeric small molecules for the recruitment of antibodies to cancer cells
10/14/2014US8859501 Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
10/14/2014US8859488 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
10/14/2014US8859257 Vaccinia virus mutants containing the major genomic deletions of MVA
10/14/2014US8859240 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
10/14/2014US8859234 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
10/14/2014US8859233 Method for immunizing an avian species
10/14/2014US8859231 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
10/14/2014US8859209 Reimmunization and antibody design
10/14/2014US8859208 System producing infectious recombinant influenza virus
10/14/2014US8859198 Detection and use of antiviral resistance mutations
10/14/2014US8858962 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
10/14/2014US8858959 Gel vaccine delivery system for treating poultry
10/14/2014US8858958 Adjuvant comprising aluminum, oligonucleotide and polycation
10/14/2014US8858957 GAS57 mutant antigens and GAS57 antibodies
10/14/2014US8858955 Process for manufacturing vaccines
10/14/2014US8858952 Methods and materials for generating T cells
10/14/2014US8858951 Compositions for eliciting an immune response
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 1823